Quantcast
Home > Quotes > TORC
x

resTORbio, Inc. Common Stock (TORC) Quote & Summary Data

TORC 
$12.37
*  
0.30
2.37%
Get TORC Alerts
*Delayed - data as of Oct. 18, 2018 10:29 ET  -  Find a broker to begin trading TORC now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    TORC Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 12.34 / $ 12.42
1 Year Target
30
Today's High / Low
$ 12.69 / $ 12
Share Volume
9,532
50 Day Avg. Daily Volume
141,948
Previous Close
$ 12.67
52 Week High / Low
$ 21.0974 / $ 7.5461
Market Cap
346,957,657
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
2.31

Intraday Chart

Shares Traded

Share Volume:
9,532
50 Day Avg. Daily Volume:
141,948

Trading Range

The current last sale of $12.37 is 63.93% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 12.69 $ 21.0974
 Low: $ 12 $ 7.5461

Company Description (as filed with the SEC)

We are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. Our lead program has demonstrated in several clinical trials, including a randomized, placebo-controlled trial, the potential to treat multiple diseases of aging for which there are no approved therapies. The decline in immune function that occurs during aging, or immunosenescence, increases susceptibility to a variety of diseases, including respiratory tract infections, or RTIs, that significantly contribute to morbidity and mortality in the elderly. Our approach focuses on the mechanistic target of rapamycin, or mTOR, pathway, an evolutionarily conserved pathway that regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1, or TORC1.  ... More ...  


Risk Grade

Where does TORC fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 12.69
Open Date:
Oct. 18, 2018
Close Price:
$ 12.67
Close Date:
Oct. 17, 2018

Consensus Recommendation

Analyst Info